Rafael Holdings, Inc. (RFL) stock
RFLNYSEPharmaceutical PreparationsFiscal year ends July 31
$1.07−0.04 (-3.60%)
Close on Nov 13, 2026Market cap $55.84MP/E –Yield –
Rafael operating margin
Operating margin is operating income as a percentage of revenue.
Rafael's operating margin for the twelve months ending Jul 31, 2026 was -3822.5%. For fiscal 2026 it was -3822.5%, against -3179.8% the year before. The highest annual figure on record is 21.3% in fiscal 2016.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Jul 31, 2026 | -3822.5% | −642.7 |
| FY2025 | Jul 31, 2025 | -3179.8% | +12931.2 |
| FY2024 | Jul 31, 2024 | -16111.0% | −10719.2 |
| FY2023 | Jul 31, 2023 | -5391.8% | +9358.7 |
| FY2022 | Jul 31, 2022 | -14750.5% | −11234.4 |
| FY2021 | Jul 31, 2021 | -3516.1% | −3343.7 |
| FY2020 | Jul 31, 2020 | -172.4% | −36.6 |
| FY2019 | Jul 31, 2019 | -135.8% | −47.9 |
| FY2018 | Jul 31, 2018 | -87.9% | −91.8 |
| FY2017 | Jul 31, 2017 | 3.9% | −17.4 |
| FY2016 | Jul 31, 2016 | 21.3% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jul 31, 2026 | -3988.1% | −341.5 |
| Q3 FY2026CQ1 2026 | Apr 30, 2026 | -3838.0% | −2204.6 |
| Q2 FY2026CQ4 2025 | Jan 31, 2026 | -3154.0% | +5468.0 |
| Q1 FY2026CQ3 2025 | Oct 31, 2025 | -4225.4% | −1222.3 |
| Q4 FY2025CQ2 2025 | Jul 31, 2025 | -3646.6% | −1316.3 |
| Q3 FY2025CQ1 2025 | Apr 30, 2025 | -1633.4% | +26093.1 |
| Q2 FY2025CQ4 2024 | Jan 31, 2025 | -8622.1% | −4000.0 |
| Q1 FY2025CQ3 2024 | Oct 31, 2024 | -3003.1% | +641.0 |
| Q4 FY2024CQ2 2024 | Jul 31, 2024 | -2330.3% | +1509.4 |
| Q3 FY2024CQ1 2024 | Apr 30, 2024 | -27726.5% | −23457.5 |
| Q2 FY2024CQ4 2023 | Jan 31, 2024 | -4622.1% | +1462.2 |
| Q1 FY2024CQ3 2023 | Oct 31, 2023 | -3644.1% | +3701.6 |
| Q4 FY2023CQ2 2023 | Jul 31, 2023 | -3839.7% | +3171.9 |
| Q3 FY2023CQ1 2023 | Apr 30, 2023 | -4269.0% | +1902.0 |
| Q2 FY2023CQ4 2022 | Jan 31, 2023 | -6084.3% | −3923.5 |
| Q1 FY2023CQ3 2022 | Oct 31, 2022 | -7345.7% | +18590.4 |
| Q4 FY2022CQ2 2022 | Jul 31, 2022 | -7011.6% | −5833.9 |
| Q3 FY2022CQ1 2022 | Apr 30, 2022 | -6171.1% | −5819.6 |
| Q2 FY2022CQ4 2021 | Jan 31, 2022 | -2160.8% | −1032.9 |
| Q1 FY2022CQ3 2021 | Oct 31, 2021 | -25936.1% | −25699.6 |
| Q4 FY2021CQ2 2021 | Jul 31, 2021 | -1177.7% | −931.6 |
| Q3 FY2021CQ1 2021 | Apr 30, 2021 | -351.4% | −190.9 |
| Q2 FY2021CQ4 2020 | Jan 31, 2021 | -1127.9% | −973.7 |
| Q1 FY2021CQ3 2020 | Oct 31, 2020 | -236.6% | −109.1 |
| Q4 FY2020CQ2 2020 | Jul 31, 2020 | -246.1% | −49.8 |
| Q3 FY2020CQ1 2020 | Apr 30, 2020 | -160.5% | −57.6 |
| Q2 FY2020CQ4 2019 | Jan 31, 2020 | -154.2% | −16.0 |
| Q1 FY2020CQ3 2019 | Oct 31, 2019 | -127.4% | −28.8 |
| Q4 FY2019CQ2 2019 | Jul 31, 2019 | -196.3% | −94.2 |
| Q3 FY2019CQ1 2019 | Apr 30, 2019 | -103.0% | −36.1 |
| Q2 FY2019CQ4 2018 | Jan 31, 2019 | -138.2% | −52.9 |
| Q1 FY2019CQ3 2018 | Oct 31, 2018 | -98.7% | −3.3 |
| Q4 FY2018CQ2 2018 | Jul 31, 2018 | -102.1% | −108.4 |
| Q3 FY2018CQ1 2018 | Apr 30, 2018 | -66.9% | −54.1 |
| Q2 FY2018CQ4 2017 | Jan 31, 2018 | -85.4% | −94.9 |
| Q1 FY2018CQ3 2017 | Oct 31, 2017 | -95.4% | – |
| Q4 FY2017CQ2 2017 | Jul 31, 2017 | 6.3% | – |
| Q3 FY2017CQ1 2017 | Apr 30, 2017 | -12.8% | – |
| Q2 FY2017CQ4 2016 | Jan 31, 2017 | 9.5% | – |
See a number that looks wrong?